Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas - Related Studies

Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas

This study is ongoing, but not recruiting participants.

Study NCT00019513. Last updated on October 18, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Colorectal Cancer
		Esophageal Cancer
		Extrahepatic Bile Duct Cancer
		Gallbladder Cancer
		Liver Cancer
		Lung Cancer
		Lymphoma
		Pancreatic Cancer
		Small Intestine Cancer

2	Additional conditions recognized in this trial
		Bile Duct Neoplasms
		Colorectal Neoplasms
		Duodenal Neoplasms
		Esophageal Diseases
		Esophageal Neoplasms
		Gallbladder Neoplasms
		Ileal Neoplasms
		Intestinal Neoplasms
		Jejunal Neoplasms
		Liver Neoplasms
		Lung Neoplasms
		Pancreatic Neoplasms

3	More general conditions related to this trial
		Bile Duct Diseases
		Biliary Tract Diseases
		Biliary Tract Neoplasms
		Colonic Diseases
		Digestive System Diseases
		Digestive System Neoplasms
		Duodenal Diseases
		Endocrine Gland Neoplasms
		Endocrine System Diseases
		Gallbladder Diseases
		Gastrointestinal Diseases
		Gastrointestinal Neoplasms
		Head and Neck Neoplasms
		Ileal Diseases
		Immune System Diseases
		Immunoproliferative Disorders
		Intestinal Diseases
		Jejunal Diseases
		Liver Diseases
		Lung Diseases
		Lymphatic Diseases
		Lymphoproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Pancreatic Diseases
		Rectal Diseases
		Respiratory Tract Diseases
		Respiratory Tract Neoplasms
		Thoracic Neoplasms

4	Interventions listed in this trial
		fluorouracil
		gemcitabine hydrochloride
		leucovorin calcium

5	Additional drug interventions recognized in this trial
		Gemcitabine
		Leucovorin

6	More general drug interventions related to this trial
		Anti-Infective Agents
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Antiviral Agents
		Enzyme Inhibitors
		Growth Substances
		Immunologic Factors
		Immunosuppressive Agents
		Micronutrients
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Radiation-Sensitizing Agents
		Therapeutic Uses
		Vitamin B Complex
		Vitamins

7	Sponsors listed in this trial
		NCI - Center for Cancer Research-Medical Oncology
		National Cancer Institute (NCI)